Oral Lichen Planus clinical trials

Explore recruiting oral lichen planus clinical trials.

Recruiting oral lichen planus studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Oral Lichen Planus trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Proof of concept study (multicenter, phase II) on the efficacy of the selective TYK2 inhibitor Deucravacitinib in Lichen planus patients (DEUCRALIP)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Upadacitinib in adult patients with erosive mucosal Lichen Planus and Lichen Planopilaris: a prospective multicenter randomized placebo-controlled study. (Upa30-LP)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Oral Lichen Planus trials by city

Oral Lichen Planus in Toronto Oral Lichen Planus in Vancouver Oral Lichen Planus in Montreal Oral Lichen Planus in Calgary Oral Lichen Planus in Edmonton Oral Lichen Planus in Ottawa Oral Lichen Planus in Winnipeg Oral Lichen Planus in Quebec City Oral Lichen Planus in Hamilton Oral Lichen Planus in Kitchener Oral Lichen Planus in London Oral Lichen Planus in Halifax Oral Lichen Planus in New York Oral Lichen Planus in Los Angeles Oral Lichen Planus in Chicago Oral Lichen Planus in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease